{"schema_version":"secwatch.filing_event.v1","accession":"0001524472-24-000013","form_type":"8-K","ticker":"XYL","cik":"0001524472","company_name":"Xylem Inc.","filed_at":"2024-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.816068+00:00","generated_at":"2026-06-03T00:24:31.174490+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Xylem beats Q1 estimates, raises FY revenue and adjusted EPS guidance","bullets":["Q1 revenue of $2.0B (+40% reported, +7% organic); orders $2.2B (+43% reported, +3% organic).","GAAP EPS $0.63 (+17%); adjusted EPS $0.90 (+14%); net income $153M; adjusted net income $219M.","FY 2024 revenue guidance raised to ~$8.5B (+15-16% reported, +4-6% organic).","Adjusted EPS guidance raised to $4.10-$4.25 from $4.00-$4.20; adjusted EBITDA margin now ~20%.","Record Q1 margins driven by productivity, favorable mix; Evoqua integration on track."],"urls":{"canonical":"https://secwatch.observer/filing/0001524472-24-000013","json":"https://secwatch.observer/filing/0001524472-24-000013.json","markdown":"https://secwatch.observer/filing/0001524472-24-000013.md","text":"https://secwatch.observer/filing/0001524472-24-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1524472/000152447224000013/0001524472-24-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1524472/000152447224000013/xyl-20240502.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T00:24:31.174490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8db94905c79d4b764b87f5d6ec7e284dfa8c76c1","claim":"Xylem Inc. reported the quarter ended March 31, 2024 results: revenue $2.0 billion, net income $153 million, EPS $0.63 per share. Guidance raised.","evidence_excerpt":"Xylem Reports First Quarter 2024 Results and Raises Full-Year Guidance • Orders of $2.2 billion, up 43% on a reported basis and 3% organically • Revenue of $2.0 billion, up 40% on a reported basis and 7% organically • Earnings per share of $0.63, up 17%; $0.90 on an adjusted basis, up 14% • Raising full-year revenue guidance to approximately","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1524472/000152447224000013/0001524472-24-000013-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$2.0 billion"},{"label":"Net income","value":"$153 million"},{"label":"EPS","value":"$0.63 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}